Leapcure在2024年8月获得蜜蜂试验,以改善临床试验服务。 Leapcure acquires Honeybee Trials in August 2024 to improve clinical trial services.

Leapcure是一家开创性的临床试验公司,它购买了蜜蜂试验,以加强临床试验和负担得起的病人招聘。 Leapcure, a pioneering clinical trial company, acquires Honeybee Trials in an effort to enhance clinical trials and affordable patient recruitment. 这笔购置款将帮助Leapcure执行任务,在临床试验方面提供更好的病人和现场经验,使他们能够在医院和学术场所适应数字时代时,为它们带来更负担得起的解决办法。 This acquisition will aid Leapcure's mission to provide better patient and site experiences in clinical trials, enabling them to bring more affordable solutions to hospitals and academic sites as they adapt to the digital age. 这项交易于2024年8月13日宣布。 The deal was announced on August 13, 2024.